E-therapeutics Plc (ETXPF)
Stock analysis · OTC · Healthcare · Biotechnology
E-therapeutics Plc (ETXPF) is a publicly traded company in the Healthcare sector. Latest price: $0.13. Market cap $75.96M. Trailing PE -4.82. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About E-therapeutics Plc
E-therapeutics Plc is a UK-based company focused on drug discovery. The core of its work involves a sophisticated computational platform that employs in-silico screening and unique network models to identify and predict which compounds or biological targets can effectively alter relevant biological processes. Furthermore, the company is advancing an RNA interference (RNAi) platform designed for highly specific gene silencing. Founded in 2001, E-therapeutics Plc operates from its headquarters in London, United Kingdom.
Valuation
| P/E (TTM) | -4.82× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | 1.99× |
| P/FCF (TTM) | -3.33× |
| EV / EBITDA | -2.01× |
| EV / Sales | 0.00× |
| Earnings Yield | -20.74% |
| Free Cash Flow Yield | -30.00% |
Fundamentals
| Enterprise Value | $36.36M |
|---|---|
| Net Income (TTM) | -$11.73M |
| Free Cash Flow (TTM) | -$16.97M |
| Net Debt | -$20.20M |
| Working Capital | $34.42M |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | -51.21% |
| Return on Invested Capital | -51.24% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap